Change in patient-reported Minnesota Living with Heart Failure Questionnaire (MLHFQ)-score by decrease in pleural effusion (cm)
| Model | Adjustments | ß-coefficient (95% CI) |
|---|---|---|
| Model 1 | Age | 3.1 (1.1 to 5.0) |
| Model 2 | Age + sex | 3.1 (1.0 to 5.2) |
| Model 3 | Model 1+ beta-blockers | 3.2 (1.3 to 5.2) |
| Model 4 | Model 1+ bumetanide equivalent (in mg) | 3.1 (1.1 to 5.0) |
| Model 5 | Model 1+ weight (change over time) | 3.2 (0.8 to 5.5) |
| Model 6 | Model 1+ACEI or ARB | 3.1 (0.9 to 5.2) |
| Model 7 | Model 1+ systolic BP (change over time) | 3.0 (0.6 to 5.5) |
ß indicates the decrease in MLHFQ-score per cm decrease of PLE (95% CI) over time.
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BP, blood pressure (mm Hg).